HK1154032A1 - A process for the ultrapurification of alginates - Google Patents

A process for the ultrapurification of alginates

Info

Publication number
HK1154032A1
HK1154032A1 HK11108357.7A HK11108357A HK1154032A1 HK 1154032 A1 HK1154032 A1 HK 1154032A1 HK 11108357 A HK11108357 A HK 11108357A HK 1154032 A1 HK1154032 A1 HK 1154032A1
Authority
HK
Hong Kong
Prior art keywords
ultrapurification
alginates
microencapsulation
human cell
cell transplants
Prior art date
Application number
HK11108357.7A
Other languages
English (en)
Inventor
Giuseppe Pietro Pio Basta
Riccardo Calafiore
Original Assignee
Gh Care Inc D B A Altucell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gh Care Inc D B A Altucell Inc filed Critical Gh Care Inc D B A Altucell Inc
Publication of HK1154032A1 publication Critical patent/HK1154032A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
HK11108357.7A 2008-01-23 2011-08-10 A process for the ultrapurification of alginates HK1154032A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000037A ITRM20080037A1 (it) 2008-01-23 2008-01-23 Procedimento per la ultrapurificazione di alginati.
PCT/IB2009/050221 WO2009093184A1 (en) 2008-01-23 2009-01-21 A process for the ultrapurification of alginates

Publications (1)

Publication Number Publication Date
HK1154032A1 true HK1154032A1 (en) 2012-04-20

Family

ID=40290324

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11108357.7A HK1154032A1 (en) 2008-01-23 2011-08-10 A process for the ultrapurification of alginates

Country Status (13)

Country Link
US (2) US8765937B2 (ru)
EP (1) EP2235066B1 (ru)
JP (1) JP5684575B2 (ru)
KR (1) KR101615267B1 (ru)
CN (1) CN101977938B (ru)
AU (1) AU2009207386B2 (ru)
CA (1) CA2712904C (ru)
HK (1) HK1154032A1 (ru)
IL (1) IL207190A (ru)
IT (1) ITRM20080037A1 (ru)
NZ (1) NZ586978A (ru)
RU (1) RU2560944C2 (ru)
WO (1) WO2009093184A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3593807B1 (en) 2017-03-07 2023-09-06 Mochida Pharmaceutical Co., Ltd. Alginate liquid formulation
CN107188988A (zh) * 2017-06-28 2017-09-22 暨南大学 一种生物医用海藻酸钠的纯化方法
CN110804108B (zh) * 2019-11-19 2021-11-23 青岛明月藻酸盐组织工程材料有限公司 一种体内植入用水溶性海藻酸盐的制备方法
US11685794B1 (en) * 2022-02-14 2023-06-27 Iurii Uss Method of industrial extraction of alginates from brown seaweed of the family sargassaceae of the order fucales

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683092A (en) 1985-07-03 1987-07-28 Damon Biotech, Inc. Capsule loading technique
FR2645439B1 (fr) * 1989-04-07 1991-06-21 Oreal Procede de preparation de capsules d'alginate(s) particulierement adaptees a un usage cosmetique, appareil pour sa mise en oeuvre et composition cosmetique contenant lesdites capsules
AU3065192A (en) * 1991-12-20 1993-07-28 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
US6963920B1 (en) * 1993-11-19 2005-11-08 Rose Blush Software Llc Intellectual asset protocol for defining data exchange rules and formats for universal intellectual asset documents, and systems, methods, and computer program products related to same
US5999907A (en) * 1993-12-06 1999-12-07 Donner; Irah H. Intellectual property audit system
WO2000029449A1 (en) 1998-11-13 2000-05-25 Cp Kelco U.S. Inc. Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same
US20020002524A1 (en) * 1999-03-17 2002-01-03 Nir Kossovsky Online patent and license exchange
US6556992B1 (en) * 1999-09-14 2003-04-29 Patent Ratings, Llc Method and system for rating patents and other intangible assets
JP3791328B2 (ja) * 2000-11-21 2006-06-28 独立行政法人食品総合研究所 変性タンパク質の活性化方法
US20020082973A1 (en) * 2000-12-27 2002-06-27 Alain Marbach Intellectual property bid method and system
US20020150944A1 (en) * 2001-04-06 2002-10-17 Fuji Photo Film Co., Ltd. Biochemical analysis unit and method for exposing stimulable phosphor sheet using the same
US7038016B2 (en) 2001-08-21 2006-05-02 Apex Bioscience, Inc. Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution
US7257548B2 (en) * 2002-06-14 2007-08-14 Oldcastle Glass, Inc. Method, apparatus and system for selecting, ordering and purchasing glass products
US7206987B2 (en) * 2003-04-30 2007-04-17 Hewlett-Packard Development Company, L.P. Error detection and correction in a layered, 3-dimensional storage architecture
US20070225727A1 (en) * 2004-05-31 2007-09-27 Keiichi Matsuhisa Transparent Tissue-Visualizng Preparation
US7509663B2 (en) * 2005-02-14 2009-03-24 Time Warner Cable, Inc. Technique for identifying favorite program channels for receiving entertainment programming content over a communications network
US20070214314A1 (en) * 2006-03-07 2007-09-13 Reuter James M Methods and systems for hierarchical management of distributed data
US20080052328A1 (en) * 2006-07-10 2008-02-28 Elephantdrive, Inc. Abstracted and optimized online backup and digital asset management service
EP2044488A1 (en) * 2006-07-21 2009-04-08 Entegris, Inc. Apparatus and method for conditioning an immersion fluid
US20080140786A1 (en) * 2006-12-07 2008-06-12 Bao Tran Systems and methods for commercializing ideas or inventions
US7536357B2 (en) * 2007-02-13 2009-05-19 International Business Machines Corporation Methodologies and analytics tools for identifying potential licensee markets
US7930611B2 (en) * 2007-03-09 2011-04-19 Microsoft Corporation Erasure-resilient codes having multiple protection groups
US7693877B1 (en) * 2007-03-23 2010-04-06 Network Appliance, Inc. Automated information lifecycle management system for network data storage
US20100023424A1 (en) * 2007-07-17 2010-01-28 CJPS Enterprises, LLC Online marketplace for intellectual property
CA2710413A1 (en) * 2007-12-21 2009-07-09 Thomson Reuters Global Resources Systems, methods, and software for an intellectual property relationship warehouse and monitor
WO2009108784A2 (en) * 2008-02-26 2009-09-03 Cloudtrade Llc System and method for transferring digital media
US8019728B2 (en) * 2008-04-17 2011-09-13 Nec Laboratories America, Inc. Dynamically quantifying and improving the reliability of distributed data storage systems
US20090318077A1 (en) * 2008-06-18 2009-12-24 Microsoft Corporation Television Audio via Phone
US20100218037A1 (en) * 2008-09-16 2010-08-26 File System Labs Llc Matrix-based Error Correction and Erasure Code Methods and Apparatus and Applications Thereof
TWI369113B (en) * 2008-12-10 2012-07-21 Wistron Corp Communication method capable of connecting a communication application service and gateway thereof
US8458287B2 (en) * 2009-07-31 2013-06-04 Microsoft Corporation Erasure coded storage aggregation in data centers
US8473778B2 (en) * 2010-09-08 2013-06-25 Microsoft Corporation Erasure coding immutable data
US8621330B2 (en) * 2011-03-21 2013-12-31 Microsoft Corporation High rate locally decodable codes
US9141679B2 (en) * 2011-08-31 2015-09-22 Microsoft Technology Licensing, Llc Cloud data storage using redundant encoding

Also Published As

Publication number Publication date
WO2009093184A1 (en) 2009-07-30
RU2560944C2 (ru) 2015-08-20
CN101977938B (zh) 2013-03-13
KR101615267B1 (ko) 2016-04-25
IL207190A (en) 2015-04-30
NZ586978A (en) 2012-03-30
US20100298262A1 (en) 2010-11-25
US8765937B2 (en) 2014-07-01
RU2010135753A (ru) 2012-02-27
CN101977938A (zh) 2011-02-16
EP2235066A1 (en) 2010-10-06
ITRM20080037A1 (it) 2009-07-24
US20140275519A1 (en) 2014-09-18
CA2712904A1 (en) 2009-07-30
KR20100122477A (ko) 2010-11-22
AU2009207386B2 (en) 2014-03-06
JP5684575B2 (ja) 2015-03-11
CA2712904C (en) 2016-07-19
JP2011510150A (ja) 2011-03-31
EP2235066B1 (en) 2017-04-26
IL207190A0 (en) 2010-12-30
AU2009207386A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
MX339878B (es) Nuevas formas solidas de clorhidrato de bendamustina.
EP3539380A3 (en) Improved cell composition and methods of making the same
NZ597517A (en) 5-fluoropyrimidinone derivatives
WO2009149956A3 (en) Fusion protein and use thereof
MY159971A (en) Multipotent/pluripotent cells and methods
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
MX354137B (es) Composiciones topicas de minociclina y metodos de uso de la misma.
ZA200906853B (en) Aqueous hydrogen peroxide solution, process for its preparation and use thereof
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
TW200942524A (en) Novel aminomethyl benzene derivatives
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
WO2009102569A3 (en) Cell lines and methods for making and using them
MY161601A (en) Films and compositions comprising the same
MY155330A (en) Methods for salt production
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
GB201316955D0 (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
HK1154032A1 (en) A process for the ultrapurification of alginates
WO2011029102A3 (en) Cd117+cells and uses thereof
UA103197C2 (ru) Применение нифуртимокса для лечения болезней, вызванных трихомонадами
EA201000864A1 (ru) Фенилоксетанильные производные
EP2471542A4 (en) THERAPEUTIC AGENT FOR HEPATIC DISEASES
ATE556446T1 (de) Batterieanoden
AP2011005596A0 (en) Use of hydroxy-2-hydroxymethyl-y-pyrone (HMP) as aleishmanicidal agent.
UA38295U (ru) Способ аллопластики параколостомической грыжи при ликвидации колостомы